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Bdellovibrio bacteriovorus HD100 is a predatory bacterium that attacks many Gram-negative human
pathogens. A serious drawback of this strain, however, is its ineffectiveness against Gram-positive strains,
such as the human pathogen Staphylococcus aureus. Here we demonstrate that the extracellular proteases
produced by a host-independent B. bacteriovorus (HIB) effectively degrade/inhibit the formation of S.
aureus biofilms and reduce its virulence. A 10% addition of HIB supernatant caused a 75% or greater
reduction in S. aureus biofilm formation as well as 75% dispersal of pre-formed biofilms. LC-MS-MS
analyses identified various B. bacteriovorus proteases within the supernatant, including the serine proteases
Bd2269 and Bd2321. Tests with AEBSF confirmed that serine proteases were active in the supernatant and
that they impacted S. aureus biofilm formation. The supernatant also possessed a slight DNAse activity.
Furthermore, treatment of planktonic S. aureus with the supernatant diminished its ability to invade
MCF-10a epithelial cells by 5-fold but did not affect the MCF-10a viability. In conclusion, this study
illustrates the hitherto unknown ability of B. bacteriovorus to disperse Gram-positive pathogenic biofilms
and mitigate their virulence.
M
ultidrug resistance in human pathogens is a growing concern as the number of patients infected with
these bacteria is increasing1–3. This resistive facet is further exacerbated as many chronic human diseases
are biofilm associated4. This poses a serious threat to human health since bacteria present within biofilms
are naturally more resistant to antibiotic treatments5, even without the requisite genetic markers for antibiotic
resistance.
Recent studies have shown that Bdellovibrio bacteriovorus and other similar organisms, collectively referred to
as BALOs (Bdellovibrio-and-like-organisms)6,7, predate upon Gram-negative human pathogens8,9, including
multidrug resistant Acinetobacter baumannii1. B. bacteriovorus was also shown to be a very promising tool for
combating biofilms10–12. This was attributed to the ability of this bacterium to penetrate deeply inside prey
biofilms and effectively destroy them; a characteristic which distinguishes them from other biological tools such
as bacteriophages and protists12. Amajor limitation of BALOs, however, is their inability to attack or predate upon
Gram-positive strains8,10,13, a category that comprises numerous human pathogens14,15, including Staphylococcus
aureus, one of the most frequent nosocomial infection-associated multidrug resistant pathogens isolated from
patients16,17.
S. aureus commonly colonizes the skin or within the nasal passage of humans18, but is also able to form biofilms
on a variety of abiotic surfaces, including medical equipment, catheters, implants and prosthetics19–21. Biofilms
formed by S. aureus, as with all bacteria, are composed of bacterial cells embedded within a matrix called the
extracellular polymeric substances (EPS)22. This EPS matrix is formed using extracellular DNA, polysaccharides
and proteins and anchors the cells to the surface, making it difficult to eradicate the organism once it establishes
itself. To address this need with S. aureus, several groups have evaluated the use of hydrolytic enzymes, including
proteases and DNases, to degrade the EPS and, thus, remove and disperse the unwanted biofilms16,18,23.
As a predator, B. bacteriovorus HD100 produces numerous hydrolytic enzymes that are needed for it to
effectively hydrolyze its prey’s macromolecules, including a cache of 150 proteases/peptidases24 and numerous
other hydrolases.With this extensive arsenal in its genome, B. bacteriovorusHD100 is thought to have the highest
number of protease genes per unit genome of all reported bacterial strains24. Whereas the production of these
proteins is expected to occur during its intraperiplasmic stage of predation inside the prey cell, several studies
found that cultures of host independent (HI) mutants of B. bacteriovorus possess a strong extracellular protease
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activity25,26. Consequently, this study aimed at evaluating and util-
izing the strong hydrolytic arsenal of B. bacteriovorus against S.
aureus biofilms.
Results
Host-independent Bdellovibrio bacteriovorusHD100 release pro-
teases into the media. A host-independent mutant of B. bacterio-
vorus (HIB) isolated in our lab was cultivated axenically in PYE
media. This strain was selected since similarly developed host-
independent isolates from other groups are known to secrete
proteolytic enzymes25. When the cell-free supernatant from our
isolate at mid-log phase (OD600 0.5) was likewise assayed, we
found that it harboured a proteolytic activity corresponding to 13.7
6 7.4 ng/ml proteinase K.
Bdellovibrio bacteriovorus supernatant significantly inhibits S.
aureus biofilm formation. Wild-type B. bacteriovorus HD100 is
capable of attacking many different Gram-negative pathogenic
bacterial strains, as shown in Fig. 1A. The optical densities from
each of the species tested, including a variety of Yersinia strains,
were significantly mitigated by predation. Growth of Staphylo-
coccus aureus, the causative agent of many skin infections and the
most commonmultidrug resistant organism related with nosocomial
infections27, however, was not affected by this predatory bacterium.
This was not surprising as this organism is Gram-positive and not
attacked by B. bacteriovorus HD100.
S. aureus biofilm formation, however, is susceptible to proteinase
K28. With HI B. bacteriovorus HD100 cultures releasing proteases
into the media, we were intrigued by the idea that this predator and
its secreted hydrolytic enzymes may block biofilm formation by S.
aureus. This was the case as shown in Fig. 1B where 10% addition of
the HIB cell-free spent media was able to prevent S. aureus biofilm
formation by 80 to 90%. An image of the stained biofilms is provided
in Supp. Fig. S1. Although the commonly reported proteinase K
concentrations used in preventing and removing S. aureus biofilms
ranges from about 1 or 2 mg/ml28,29 to 100 mg/ml30, this study found
that proteinase K at a concentration of 1 ng/ml still led to an average
inhibition of 63%. These results are in agreement with our findings
with the HIB supernatants and their low proteolytic activities, which
are comparable to 1.4 ng/ml proteinase K after 10% dilution. It is
Figure 1 | (A) The prey spectrum of B. bacteriovorus HD100. Each prey was incubated in DNB medium in the presence or absence of the predator
and the OD600 was measured after 24 h. A decreased OD600 in the presence of the predator was indicative that this prey was predated upon. The
pathogenic prey evaluated are S. enterica (Se), Y. bercovieri (Yb), Y. enterocolitica (Ye), Y. pseudotuberculosis (Yp), Y. rohdei (Yr), A. baumannii (Ab), a
clinical isolate ofA. baumannii (Ab-CI) and S. aureus (Sa) (* p, 0.05, ** p, 0.01, *** p, 0.001). The initial OD600 value of each culture was: 0.18, 0.17,
0.17, 0.18, 0.15, 0.25, 0.25 and 0.4, respectively. (B) Prevention of S. aureus biofilm formation using culture supernatant from host-independent
B. bacteriovorusHD100 (HIB). The supernatant was added (10%) to the S. aureus culture in 96-well plates. For the control wells, 10% fresh PYEmedium
was added (*** 5 P , 0.001). (C) Effect of different concentrations of Proteinase K on S. aureus-biofilm formation in 96 well plates. Proteinase
Kwas serially diluted in PYEmedium and added (10%) to the S. aureus culture in 96-well plates (a, b, c, and d5 P, 0.05). (D) HIB culture supernatants
have no effect on S. aureus growth. Fresh S. aureus cultures were diluted 100-fold in TSBmedium supplemented with 10% fresh PYE or HIB supernatant
in 96 well plates. The plate was incubated at 37uC with frequent shaking and S. aureus growth (OD600) was monitored over 12 h.
www.nature.com/scientificreports
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worthy to note, though, that even with the significant loss in S.
aureus’ biofilm formation, theHIB spentmedia had no obvious effect
on the growth of this pathogen (Fig. 1D) showing that the anti-
biofilm activity did not results from this supernatant being toxic to
this S. aureus.
Extracellular serine proteases contribute to S. aureus biofilm
formation inhibition. Use of a protease assay and several different
protease inhibitors, we found that treating the supernatant with AE-
BSF reduced the proteolytic activity by more than 90% (Table 1).
This indicates that serine proteases account for a majority of the
proteolytic activity seen in the HIB supernatant. Interestingly,
bestatin, an aminopeptidases inhibitor, also caused a decrease in
the proteolytic activity (,35%), indicating that aminopeptidases
are also present. The nearly 50% inhibition brought by the addi-
tion of EDTA, a metaloprotease inhibitor, is probably due to its
effect on both metaloproteases and other proteases as previous
studies showed EDTA can also deactivate some serine proteases31.
To investigate if the anti-biofilm activity of the HIB supernatant is
due to these extracellular proteases, we next tested the effects the
different protease inhibitors had within a S. aureus culture. Most
of these inhibitors had no effect (Fig. 2A), but AEBSF led to a partial
restoration in S. aureus ability to form a biofilm, i.e., from26% to 55%
that of the control. When all four inhibitors were used together in a
single sample, the results were identical with the AEBSF sample. In a
separate experiment, when EDTAwas added to the HIB supernatant
at a concentration of 5 mM30minutes prior toHIB addition to the S.
aureus culture, the anti-biofilm activity of HIB supernatant was still
present. However, in the same experiment, EDTA at this concentra-
tion (0.5 mM) slightly reduced the biofilm formed by S. aureus alone
in absence of HIB supernatant (Supp. Fig. 3). It is also worthy to note
here that the EDTA couldn’t be tested at higher concentration as its
addition to the S. aureus culture at a final concentration of 5 mM
prevented the growth of the S. aureus cells (Data not shown).
To evaluate this further and possibly identify the proteases active
against S. aureus, the HIB supernatant was fractionated using several
different molecular weight cut-off filters. The flow-through from
each was tested to determine if it retained the ability to block S.
aureus biofilm formation (Fig. 2B). Although there was some loss
in the activity with a pore size of 50 kDa or higher, themajority of the
activity was lost when the HIB was filtered through a 30 kDa pore
size filter. This suggests that the majority of the proteins responsible
for the HIB activity are between 30 and 50 kDa in size.
When the extracellular proteins between 30 and 70 kDa were
identified by mass spectrometry, numerous serine proteases were
found, including Bd2269 and Bd3857 (Table 2), reaffirming the
AEBSF results in Fig. 2A. Interestingly, two additional serine prote-
ases, Bd1444 and Bd2428, were also identified in the supernatant but
were much larger than expected based upon the sizes selected for
analysis. It is presumed that these proteins are secreted by the HIB
into the media but subsequently cleaved by other proteolytic
enzymes into smaller fragments. Aside from serine proteases, many
other proteases and peptidases were also identified and may also
contribute to the inhibition seen in Fig. 2A.
Removal of pre-formed S. aureus biofilms by HIB supernatants.
The serine protease, proteinase K, not only reduces S. aureus biofilm
formation but is also known to be effective at dispersing pre-formed
biofilms of this strain28,32,33. As many of the extracellular proteases in
the HIB supernatant were serine proteases, we next tested the ability
of the HIB supernatants to remove pre-formed S. aureus biofilms.
The results show that a 10% addition led to comparable losses as
those seen with the well-characterized proteinase K (Fig. 3A). This
was confirmed further through fluorescent microscopy and SEM
imaging (Fig. 3B), providing clear evidence that the S. aureus
biofilms are significantly dispersed by the addition of the HIB
supernatant and its activity. Furthermore, the addition of AEBSF
to the supernatant had only a minor effect on the removal
efficiency (Fig. 3A), suggesting that other hydrolytic enzymes are
also involved in the dispersal of the S. aureus biofilms.
Table 1 | Effect of different protease inhibitors on the proteolytic
activity of HIB supernatant
Inhibitors
Concentration
(mM)
Relative % remaining protease
activity of the HIB supernatant
ABESF 5000 7.99 (61.36)
EDTA 500 54.76 (64.52)
EDTA 5000 32.64 (62.86)
E-64 50 117.98 (620.09)
Bestatin 500 64.11 (65.67)
Pepstatin A 75 88.74 (612.18)
Figure 2 | (A) The effect of different protease inhibitors on the anti-
biofilm activity of the HIB supernatant. The protease inhibitors AEBSF, E-
64, bestatin, pepstatin A were added either separately or as a mixture to the
HIB supernatant. The supernatant was then incubated for 30 min before
being added at 10% to a diluted S. aureus culture in TSB medium within a
96-well plate. The plate was then incubated for 24 h, rinsed and CV stained
(a, b, and c 5 P , 0.05). (B) Approximating the molecular mass of the
active components in HIB supernatant which are responsible for S. aureus
biofilm prevention. Samples of the HIB supernatant (500 ml) were filtered
through 100, 50, 30 and 10 kDa molecular mass cut-off centrifugal filters.
The filtrate from each was then tested for the anti-biofilm activity with S.
aureus cultures (a, b, c, d and e 5 P , 0.05).
www.nature.com/scientificreports
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As our results show that DNAse I can also disperse the S. aureus
biofilms (Fig. 3A), a finding corroborated by other groups16, we
tested the HIB supernatant for DNAse activity. Supp. Fig. S3 shows
that the supernatant also possesses some DNAse activity. Measuring
it quantitatively found it to be equivalent to ,0.07 6 0.03 mg/ml
DNAse I. This activity, however, is too low to affect S. aureus biofilms
alone as shown in Supp. Fig. S4, where DNAse I concentrations
below ,6 mg/ml didn’t have a significant effect on the pre-formed
S. aureus biofilms. Likewise, attempts to detect b-D-glucosaminidase
activities within the HIB supernatant were unsuccessful (Data not
shown).
Treatment of S. aureus with the HIB supernatant reduces its
virulence and invasion. Treatment of S. aureus with the HIB super-
natant not only reduced its ability to form or maintain biofilms but
also its ability to invade human epithelial cells (Fig. 4). Fig. 4A is a
confocal image showing one of the MCF-10a cells harbouring two
internalized S. aureus bacteria. Treatment of the S. aureus culture
with 10% HIB supernatant for 2 h reduced the number of invasion
events by nearly 5-fold when compared with the untreated bacterial
culture (Fig. 4B). An SDS-PAGE analysis shows that the treatment
significantly reduced the presence of S. aureus surface proteins
(Fig. 4C), a group that includes assorted virulence factors35,36. Fur-
thermore, when the HIB supernatant itself was tested for its effect on
the MCF-10a epithelial cells using an MTT assay, no toxicity was
detected (Fig. 5) as the epithelial cell viability was quite similar in the
control, HIB-treated and PYE-treated wells.
Discussion
It has been proposed that B. bacteriovorus HD 100 can be used as a
probiotic bacterium owing to its ability to predate upon gram nega-
tive bacterial strains and their biofilms, including those composed of
known human pathogens8,37,38. A major limitation, however, is the
inability of this predator to attack gram positive strains, a grouping
that includes the major nosocomial pathogen S. aureus. Although B.
bacteriovorus does not predate upon this strain or affect its viability,
studies have not considered B. bacteriovorus potential impact on the
biofilm stability or virulence of S. aureus.
This study found that host independent (HI) mutant of B. bacter-
iovorus produces significant amount of proteolytic enzymes in its
culturing medium. This agrees well with the studies done by other
groups who also identified proteolytic enzymes secreted by other
independently isolated HI variants of B. bacteriovorus25,26. One of
these studies used 2-D gel electrophoresis to identify the proteins
present approximately 100 protein spots39. Six of the proteases iden-
tified in their study were also found in the supernatant of our HIB
variant, including serine proteases Bd1962 and Bd2269 and the car-
boxypeptidase Bd0306. The identification of these proteins within
both of these studies through different techniques corroborates their
secretion by this strain and suggests that this may be a common trait
of all HIB mutants. As the biofilm EPSmatrix is composed of several
differentmacromolecules, including proteins, it is not surprising that
researchers have sought to use proteases to disperse pre-formed
biofilms established by Staphylococcus aureus23 and other bacteria40,41
and fungi42, as well as those composed ofmultiple strains or species43.
A recent study likewise reported that the Esp serine protease from
Staphylococcus epidermidis is capable of both inhibiting and remov-
ing S. aureus biofilms18.
The results presented here demonstrate that the HIB supernatant
possesses a sufficient hydrolytic activity to significantly inhibit or
disperse S. aureus biofilms. Furthermore, as shown in Supp. Fig.
S5, the supernatant was also effective in dispersing Staphylococcus
epidermidis biofilms. This is in contrast to a recent report that the S.
epidermidis Esp serine protease disperses S. aureus biofilms, but is
apparently not effective against its own biofilms under similar con-
ditions as colonization of patients by S. epidermidis correlates with
the absence of S. aureus18. Our results show that the HIB superna-
tants are effective against both of these pathogens.
Whereas a significant proportion of the anti-biofilm activity seen
for the HIB supernatant comes from the serine proteases based on
the experiments with the serine protease inhibitor AEBSF, our data
also suggests that additional effectors are secreted as the activity is
not completely blocked by AEBSF. This was particularly true in the
biofilm dispersal experiments (Fig. 3). It is clear that other proteases
may also be contributing as treatment with AEBSF did not comple-
tely block the proteolytic activity (Table 1). Furthermore, DNAses
are also present within the supernatants and were found to have an
equivalent activity as,0.076 0.03 mg/mlDNAse I. A previous study
also found that S. aureus biofilms can be partially inhibited, although
not dispersed, by the action of theDispersin B enzyme16, whichworks
by degrading the PNAG (poly-N-acetylglucosamine) polymer pro-
duced in the biofilm matrix of Staphylococci34. However, our
attempts to find b -D-glucosaminidase activity in the HIB supernat-
Table 2 | Proteases and peptidases identified by mass spectrometry within the HIB supernatant. The size range used for the analysis was
approximately between 30 and 70 kDa
Gene Uniprot Accession Protein Name Size (kDa) Subcellular Localization
Proteases
Bd2269 Q6MKV8 Serine protease, subtilase family 56.6 Extracellular
Bd2675 Q6MJU3 Putative membrane protein with protease subunit 33.5 Unknown
Bd2321 Q6MKR4 Subtilisin-like serine protease 74.9 Unknown
Bd2428 Q6MKG5 Serine protease 114.9 Extracellular
Bd1444 Q6MN19 Serine protease, subtilase family 111.5 Unknown
Bd2692 Q6MJS6 Protease 53 Extracellular
Bd2627 Q6MJY9 Periplasmic protease 32.3 Unknown
Bd2535 Q6MK75 Putative serine protease 28.5 Unknown
Bd3857 Q6MGR5 Alkaline serine protease subtilase family 43.2 Extracellular
Bd0449 Q6MQL6 Putative protease 57.2 Unknown
Bd2675 Q6MJU3 Putative membrane protein with protease subunit 33.5 Unknown
Peptidases
Bd0306 Q6MQZ5 Carboxypeptidase 34 Unknown
Bd1962 Q6MLP5 Putative V8-like Glu-specific endopeptidase 31.3 Unknown
Bd3622 Q6MHC8 Aminopeptidase 45.6 Extracellular
cpt Q6MIC9 Carboxypeptidase N/A
dcp Q6MII6 Peptidyl-dipeptidase N/A
pip Q6MHR0 Proline iminopeptidase N/A
Bd1518 Q6MMV5 Aminopeptidase 78 Unknown
www.nature.com/scientificreports
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ant using 4-nitrophenyl-N-acetyl-b-D-glucosaminide as a substrate
were unsuccessful (Data not shown). Consequently, the HIB super-
natant contains a cocktail of degradative enzymes, including prote-
ases and nucleases, and these likely work in an orchestrated manner
to degrade the S. aureus biofilm. Individually, each hydrolytic group-
ing cannot account for the full activity observed and, as such, the
possible synergistic impact of the various DNAses and proteases may
be important and is a topic that will be studied further.
In addition to preventing and dispersing S. aureus biofilms, treat-
ment of S. aureus with the HIB supernatant significantly reduced its
virulence. A similar finding with Listeria monocytogenes was
reported previously where hydrolysis of the surface proteins, which
includes virulence factors, lowered invasion by this pathogen40. To
ascertain that this was also happening in our study, we analysed the
surface protein content of S. aureus after treatment with the HIB
supernatant and found basically identical results; HIB supernatant
treatment led to a significant reduction in the S. aureus surface pro-
tein number and content. However, a second possible explanation is
the cleavage of receptors present on the epithelial cells necessary for
S. aureus during colonization44, including fibronectin45,46, vitronec-
tin47 and fibrinogen45,48. However, this is very unlikely due to the
protocol employed as the treated S. aureus were pelleted and washed
prior to performing the invasion, thereby minimizing the transfer of
HIB proteases into the epithelial cell culture. When HIB superna-
tants were added to MFC-10a human cell cultures and the viabilities
of the cell lines were determined using the MTT assay, they were not
deleteriously affected by its addition. This confirms a recent finding
that the presence of B. bacteriovorus does not elicit a cytokine res-
ponse from human cell lines49.
In conclusion, this study shows a hitherto unknown aspect of B.
bacteriovorus hydrolytic enzymes, especially proteases, and their
impacts on Gram-positive bacterial pathogens. Based upon its mild
disposition towards human epithelial cells but strongly adverse
effects on S. aureus biofilms and virulence, HIB media may be an
option for treating and removing this pathogen both in vitro and in
vivo. This will be evaluated further in subsequent studies.
Methods
Bacterial strains and culturing conditions. The following strains were used in this
study; Staphylococcus aureusKACC 10768, Staphylococcus epidermidisKACC 13234,
Escherichia coli MG1655, Salmonella enterica KACC 11595, Yersinia bercovieri
KACC 15319, Yersinia enterocolitica KACC 15320, Yersinia pseudotuberculosis
KACC 15321, Yersinia rohdei KACC 15322; Acinetobacter baumannii KACC 12454
and a clinical isolate of A. baumannii. All were kept in frozen glycerol stocks at
280uC. Upon need, they were streaked on a nutrient broth (NB; Acumedia, USA)
agar plate and incubated at 37uC overnight. From this plate a single colony was
inoculated into 3 ml TSB broth and incubated overnight at 37uC with agitation
(250 rpm). This culture was then used for biofilm experiments as described below.
Wild-type host dependant Bdellovibrio bacteriovorus HD100 (HDB) was pur-
chased from the German Collection of Microorganisms and Cell Cultures (DSMZ).
Upon need, this strain was streaked from a frozen stock into DNB (dilute nutrient
broth) top agar plate containing E. coliMG1655 as a prey as described previously7,11.
The B. bacteriovorus liquid culture had an average of 1.5 3 109 PFU/ml.
Susceptibility of pathogenic strains to predation. Each bacterial strain was
cultivated on plates as described above and inoculated into 3 ml NB for growth
overnight at 30uC and 250 rpm. After growing, 0.5 ml of this culture was added to
4 ml DNB and cultivated once more for 24 h. For the predated culture, 0.5 ml of
attack phase B. bacteriovorus HD100 was also added. The final OD was measured at
600 nm after 24 h using a spectrophotometer (Biophotometer 1, Eppendorf,
Germany).
Isolation and culturing of the Host Independent B. bacteriovorus (HIB). Isolation
and cultivation of a host independent variant of B. bacteriovorus HD100 was
performed as described previously25. A portion of this culture was then kept as frozen
glycerol stocks at 280uC and, upon need, fresh cultures were prepared by streaking
them out on PYE agar plate. The composition of the PYE medium was peptone
(Difco, USA) 10 g/L, and yeast extract 3 g/L. After autoclaving the medium, CaCl2,
andMgCl2 were added to it at a final concentrations of 2 and 3 mM respectively. The
subcultures in PYE media were typically grown to an OD600 around 0.5. For biofilm
experiments, the culture was centrifuged (16,000 3g, 5 min) and filtered using a
0.22 mm syringe filter to remove all the cells.
Identification of the extracellular proteins by LC-MS/MS. To identify the extra
cellular proteins located in the HIB supernatant, 10 ml of 0.5 OD600 HIB culture was
taken and the bacteria were removed by centrifugation followed by filtration. The
proteins in the filtrate were precipitated using 15% trichloroacetic acid and washed
with cold acetone. The pellet was then dissolved in PBS (pH 7.4). Afterwards, the
proteins were run on a 12% Tris-glycine SDS-PAGE gel (Biorad, USA). After staining
with Coomassie blue, the proteins between 30 to 70 kDa were subjected to in-gel
Figure 3 | (A) Removal of S. aureus biofilms by HIB supernatants,
proteinase K and DNAse I. S. aureus biofilms were prepared in 96 well
plates. Afterwards, themediumwas removed, and the wells were filled with
200 ml of HEPES buffer supplemented with either 10% PYEmedium, 10%
HIB supernatant, 100 mg/ml proteinase K or 20 mg/ml DNAse I. The plates
were then incubated for 24 h more, washed and CV stained (a, b, c, and d
5 P , 0.05). (B) Confocal and SEM images for the S. aureus biofilms on
silicon chips with and without HIB supernatant treatment. S. aureus
biofilms were formed on silicon chips, washed and incubated for 24 h with
HEPES buffer supplemented with either 10% PYE medium or HIB
supernatant. The chips were then washed and analyzed. For the confocal
microscopy(Upper photos), the biofilms were stained with CFSE (green)
for the live cells and EthD-1 (red), for the dead cells and extracllular DNA.
Themiddle and the lower photos show the SEM images for the chips at low
and high magnifications, respectively.
www.nature.com/scientificreports
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tryptic digestion, as described by Shevchenko and co-workers50. The resulting tryptic
peptides were analyzed by LC-MS/MS. All mass analyses were performed on a LTQ-
Orbitrap (Thermo, Bremen, Germany) equipped with a nanoelectrospray ion source.
To separate the peptidemixture we used a C18 reverse phase HPLC column (150 mm
3 75 mm i.d.) using an acetonitrile/0.1% formic acid gradient of 66 min at a flow rate
of 300 nl/min. For MS/MS analysis the precursor ion scan MS spectra (m/z 400–
2000) were acquired in the Orbitrap at a resolution of 60,000 at m/z 400 with an
internal lock mass. The three most intensive ions were isolated and fragmented in the
linear ion trap by collisionally induced dissociation (CID).
All MS/MS spectra were analyzed by Sequest against the curated version of B.
bacteriovorus protein sequence database (3583 entries, UniProt (http://www.uniprot.
org/)) containing all the protein-coding sequences of Bdellovibrio bacteriovorus strain
ATCC 15356, DSM 50701, NCIB 9529 and HD100 and frequently observed con-
taminants. Carbamidomethyl cysteine and oxidized methionine were set as a fixed
modification and variable modification, respectively. A maximum of two missed
cleavages were allowed. The mass tolerances allowed forth MS peaks were 10 ppm,
and for the MS/MS peaks they were 0.8 Da. The search results were further filtered
with the following options: minimum number of matching peptides was 2 and the
false discovery rate was set to 0.01.
Quantitative protease assay. The protease activity in the samples was determined as
described elsewhere51. Briefly, 2 ml test samples and the prepared proteinase K
standards were added to the 0.5 ml prepared azocoll solution and incubated at 37uC
for 2 h with shaking (250 rpm). After centrifugation (16,0003g, 10 min), 200 ml of
the supernatant was transferred to a transparent 96 well plate (Costar, USA) and the
absorbance measured at 550 nm (Tecan, Infinite M200). Three independent samples
were used for each analysis. For experiments with the protease inhibitors, each
inhibitor was added to the HIB supernatant at the indicated concentration, and the
samples were incubated for 30 min at 37uC before performing the protease assay.
Size fractionation of the HIB supernatant and effect of protease inhibitors.
Samples of theHIB supernatant (0.5 ml) were passed through amolecular weight cut-
off filter (10, 30, 50 or 100 KDa (Ultracel, Amicon, USA)). The filtrate from each was
collected and tested for activity against S. aureus biofilm formation. The protease
inhibitors tested were AEBSF (4- (2-aminoethyl) benzenesulfonyl fluoride), E64,
Bestatin, and Pepstatin A, all from Sigma-Aldrich (USA) and EDTA
(ethylenediaminetetraacetic acid, Invitrogen, USA). The stock solution for each was
prepared according to the suppliers instructions. Each individual protease inhibitor
was mixed with the supernatant at a concentration of 5000, 50, 500, 75 or 5000 mM,
respectively, for 30 min before adding the supernatant to the S. aureus cultures.
Figure 5 | MTT assay to evaluate the effects of HIB supernatants on the
viability of MCF-10a human epithelial cells. The assay was performed
using VybrantHMTT Cell Proliferation Assay Kit in 96-well plates using a
72 h exposure. The results show that the HIB supernatant had no effect on
the viability of MCF-10a cells.
Figure 4 | (A) S. aureus KACC 10768 invades MCF-10a human epithelial
cells. Amonolayer culture of MCF-10a cells was stained with CFSE (green)
and co-cultured with CellTrackerTM Red CMTPX stained S. aureus.
Invasion was carried out as described inMaterials andMethods. The image
was taken at 1003magnification using a confocalmicroscope. (B) Effect of
HIB supernatant treatment on S. aureus invasion. S. aureus cells were
suspended in HEPES buffer supplemented with 10% HIB supernatant or
with 10%PYEmedia as a control for 2 h. TheHIB supernatant-treated and
untreated S. aureus cells were tested for their MCF-10a cells invasion. To
enumerate the invasive S. aureus, the MCF-10a cells were lysed and the
resulting suspension was diluted, spread on LB agar plates and the
developed colonies were counted (**5 P, 0.01). (C) SDS-PAGE analysis
of the S. aureus surface proteins after treatment with the HIB supernatant.
S. aureus cells were treated with HIB supernatant or with PYE media
(control) as in (B). After pelleting and washing the cells, the surface
proteins were purified and separated on an SDS-PAGE gel. The first and
last lanes are two different commercial pre-stained protein markers. The
HIB supernatant-treated cells clearly show a reduction in the surface
proteins still associated with the pathogen, helping to explain its lower
invasion.
www.nature.com/scientificreports
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Qualitative and quantitative DNAse activity assay. The DNAse activity was first
qualitatively assayed using the pUC19 vector. For this, equal volumes of the HIB
supernatant (or fresh PYE medium for the control) and the plasmid solution were
mixed so that the final concentration of the plasmid was 20 ng/ml. After 2 h of
incubation at 37uC, the samples were analysed by gel electrophoresis within a 1.2%
agarose gel.
For the quantitative DNAse activity measurements, the assay was performed as
described previously52, albeit with some modifications. Briefly, double-stranded
genomic DNA extracted from E. coliMG1655 was added to 20 ml of HIB supernatant
or a DNAse I standard (prepared in PYE medium) so that the final DNA concen-
tration was 100 mg/ml. The reaction mixtures were incubated for 2 h at 37uC. The
PicoGreen dsDNAquantitation kit was then used tomeasure the concentration of the
dsDNA remaining in the samples. The DNAse activity of the supernatant was then
determined relative with the DNAse I standards.
b-N-acetylglucosaminidase assay to test for glycanase activity within the HIB
supernatant. This assay was performed according to the protocol described by
Kaplan et al (2003)53. The substrate 4-nitrophenyl-N-acetyl-b-D-glucosaminide, was
purchased from Sigma-Aldrich (USA). The reaction was carried out in 1.5 ml tubes.
Samples (100 ml) of the HIB supernatant or fresh PYE medium, as a control, were
added to 900 ml of the reaction mixture (1 ml final volume). Aliquots (200 ml) were
taken over an 18 h time period and the absorbance at OD405 was measured to detect
any activity by p-nitrophenolate release.
Biofilm prevention and removal assays. To generate the biofilms, an overnight
culture of S. aureus in trypticase soy broth (TSB) medium was diluted 100 fold into
fresh TSB broth. To each well within a 96-well plate (Costar, USA), 180 ml of this
culture was added, after which, 20 ml (10%) of either PYE media, HIB supernatant or
other additives were added. The plate was incubated for 24 h at 37uCwithout shaking.
After washing carefully with distilled water and drying, 250 ml of 0.1% crystal violet
(CV) was added to each well. The plate was incubated for 20 minutes at room
temperature, washed and dried. Subsequently, 250 ml of ethanol supplemented with
2% acetic acid was added to each well for 30 min. The absorbance of each well was
then measured at 560 nm using a Glomax Multi1 (Promega, USA).
For biofilm removal tests with S. aureus or S. epidermidis, their biofilms were
prepared as described above. The medium was removed and the wells filled with
200 ml HEPES buffer (with 2 mMCaCl2 and 3 mMMgCl2) supplementedwith either
10%PYEmedium, 10%HIB supernatant, 100 mg/ml proteinase K (Invitrogen, USA),
20 mg/ml DNAse I (Invitrogen, USA) or other additives. The plates were then incu-
bated for 24 h at 37uC, washed and then stained with CV. The absorbance at 560 nm
was measured as described above.
Statistical analysis of the biofilm experiments. Each experiment was done using
three independent S. aureus cultures using at least four wells for each (total of 12 wells
for each experimental condition). To minimize the error due to plate-to-plate
handling variations, the results for each plate were analyzed relative to the control
wells for the given plate and the results from different days were then averaged
together. Statistical analysis was performed using Graphpad Prism program (version
5.01). For comparing two groups, the student t-test was used and statistical
significance was designated on the graphs using asterisks (*, **, or ***) forP values,
0.05, 0.01, and 0.001, respectively. For comparing more than two sets of data, the
ANOVA test was performed, followed by Tukey test. In this case, the statistically
significantly different groups, at P , 0.05, were designated on the graphs using
different letters (a, b, c, and d).
Biofilm formation on silicon chips. The silicon chips used in this study were 10 mm
3 10 mm chips cut from silicon wafers (Shin-Etsu, Japan). The chips and their
biofilms were prepared as described previously10.
Confocal and scanning electron microscopy. To visualize the S. aureus biofilms
formed on the silicon chips, the bacterial cells were stained by immersing the chip for
30 min in HEPES buffer containing CellTraceTM CFSE (1 mg/ml), and ethidium
homodimer-1 (EthD-1, 0.004 mM) (Life Technologies, USA). These dyes stain live
cells and dead cell/extracellular DNA, respectively. The chips were then washed
gently to remove any excess dye before imaging. Confocal microscopy was performed
using an LSM700 confocal microscope (Carl Zeiss) operated by ZEN 2009 software.
Scanning electron microscopy imaging of these biofilms was performed as described
previously10. The images shown are representatives for the results obtained from three
different chips that were prepared and analysed independently for each case.
Visualization and enumeration of invasive S. aureus.MCF-10a cell monolayer was
prepared in an 8-well chambered cover glass (NuncH Lab-TekH II, Thermo-Scientific)
by inoculating 7.5 3 104 cells/well in DMEM/F12 media. After growth for 36 h, the
MCF-10a cells were stained with CFSE by replacing the media with 0.5 ml PBS
containing 5 mg/ml CFSE and incubating for 10 minutes at 37uC in a CO2 incubator.
The cells were washed twice with PBS and then 0.5 ml of DMEM/F12 media was
added to each well. The stained cells were again incubated for 1 h at 37uC.
An overnight culture of S. aureus was centrifuged at 16,0003g for 2 minutes and
resuspended at an OD600 of 1.0 in HEPES buffer supplemented with 1 mg/ml
CellTracker Red CMTPX (Invitrogen, USA). After incubation for 20 minutes in a
shaking incubator at 37uC, the labelled bacteria were centrifuged as above andwashed
three times with HEPES buffer. The cell pellet was suspended in 1 ml HEPES buffer
and diluted 15100 into DMEM/F12 media. For the invasion, the culture media in the
well was replaced with 0.5 ml of the prepared S. aureus solution and the plate incu-
bated for 1 h at 37uC. Afterwards themedia was replaced with 1 ml freshDMEM/F12
media containing 100 unit/ml penicillin G and 100 mg/ml streptomycin (penicillin-
streptomycin mixture, Invitrogen, USA) and 50 mg/ml gentamicin (Sigma, USA) for
15 minutes. This mixture of antibiotics was used to ensure all extracellular bacteria,
i.e., those that did not invade, were killed before plating and colony enumeration as
described below. The medium was then replaced with antibiotic-free DMEM/F12
media and the culture was imaged immediately using confocal microscopy.
To enumerate the invaded bacteria, the MCF-10a cells were lysed by incubating
them at room temperature for 10 min in 1 ml PBS containing 0.2% triton X-100
(Sigma-Aldrich, USA.) followed by manual disruption. The resultant cell lysate was
serially diluted and plated out on LB agar plates to allow the colonies to grow at 37uC
for 24 h.
S. aureus surface protein extraction and processing. Three different colonies of S.
aureus were grown overnight in TSB broth. S. aureus cells from each tube were then
suspended at an OD600 of 1.0 in 5 ml HEPES buffer supplemented with either HIB
supernatant (10%) or PYE (10%) as a control. The six tubes were then incubated for
2 h at 37uC. Afterwards, the cells in each tube were centrifuged, and washed 3 times
with PBS. The proteins were isolated and run out on an SDS-PAGE gel according to
the protocol published previously40. For SDS-PAGE analysis, two commercial pre-
stained protein markers were used - PageRuler, (Thermo Scientific, USA) andWide-
View (Wako Chemical, Japan).
Assessing the impact of the HIB supernatant on MCF-10a viability. Viability
assays were performed using the VybrantHMTT Cell Proliferation Assay Kit
(Invitrogen, USA) in 96 well plates (Microtest, Falcon, USA). For this, each well was
seeded with 2500MCF-10a cells in DMEM/F12media and incubated at 37uC inside a
CO2 incubator for 24 h. Afterwards, the medium was replaced with 100 ml of fresh
culture medium supplemented with 10% of the test samples and then the plates were
incubated again for 72 h at 37uC. The medium was then removed and 100 ml of fresh
phenol red-free media supplemented with 10 ml of the 12 mM MTT stock solution
was added to each well. After 4 h incubation at 37uC, the MTT media were removed
and 100 ml of DMSO was added. The contents inside each well were mixed and the
plate was incubated again at 37uC for 10 minutes. The absorbance of each well was
then measured at 540 nm.
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